logo
Select company
Select metric
$ -212.39MConsolidated Income
VS
Market
6
Sector
10
Industry
12
History
22
$ 16.25Close
$ 5.56 - $ 16.49 52-Week Range
Ticker Information

Ticker

IMNM

Company Name

IMMUNOME INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

IMMUNOME INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMNM - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -212.39M
3/31/2025$ -205.11M
12/31/2024$ -292.96M
9/30/2024$ -305.35M
6/30/2024$ -262.59M
3/31/2024$ -232.03M
12/31/2023$ -106.81M
9/30/2023$ -21.96M
6/30/2023$ -26.15M
3/31/2023$ -29.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMMUNOME INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -17.84M.
  • Over the past 5 years, IMMUNOME INC's average Cons. Inc. has been $ -106.8M.
  • The median Cons. Inc. for IMMUNOME INC during this period was $ -36.52M
  • IMMUNOME INC reached its highest Cons. Inc. over the past 5 years at $ -17.84M.
  • The lowest Cons. Inc. recorded by IMMUNOME INC in the same timeframe $ -305.35M

IMMUNOME INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
NUVB : NUVATION BIO INC $ -202.9MQURE : UNIQURE NV $ -199MZBIO : ZENAS BIOPHARMA INC $ -177.01MTSHA : TAYSHA GENE THERAPIES INC $ -92.72MABUS : ARBUTUS BIOPHARMA CORP $ -54.25MPRAX : PRAXIS PRECISION MEDICINES INC $ -251.01MLENZ : LENZ THERAPEUTICS INC $ -52.4MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MRLAY : RELAY THERAPEUTICS INC $ -311.55MVIR : VIR BIOTECHNOLOGY INC $ -550.23M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

IMNM - Consolidated Income, Last 5 years

$ -305.35M

Minimum

Sep 30, 2024

$ -17.84M

Maximum

Dec 31, 2020

$ -106.8M

Average

$ -36.52M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.12M with a standard deviation of $ 116.68M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 378M
average$ 12.12M
median$ -2.09M
std$ 116.68M